Sequent Scientific Ltd 512529
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 122.45
- Day Range
- INR 119.75–123.30
- 52-Week Range
- INR 70.15–155.45
- Bid/Ask
- INR 0.00 / INR 0.00
- Market Cap
- INR 30.15 Bil
- Volume/Avg
- 77,043 / 127,770
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.20
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,390
- Website
- https://www.sequent.in
Comparables
Valuation
|
Metric
|
512529
|
543434
|
543064
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 26.96 | 48.76 |
Price/Book Value | 4.77 | 4.38 | 8.83 |
Price/Sales | 2.20 | 6.06 | 14.99 |
Price/Cash Flow | 233.97 | 30.79 | 38.83 |
Price/Earnings
512529
543434
543064
Financial Strength
|
Metric
|
512529
|
543434
|
543064
|
|---|---|---|---|
Quick Ratio | 0.62 | 3.14 | 7.57 |
Current Ratio | 1.28 | 6.26 | 10.40 |
Interest Coverage | −2.62 | 192.48 | 95.74 |
Quick Ratio
512529
543434
543064
Profitability
|
Metric
|
512529
|
543434
|
543064
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
512529
543434
543064
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Ftcwzynq | Jbxyd | $76.2 Bil | |
MKKGY
| Merck KGaA ADR | Fwpskjqfgb | Cmvvxw | $70.9 Bil | |
HLN
| Haleon PLC ADR | Snwjbxgc | Ptt | $37.8 Bil | |
VTRS
| Viatris Inc | Qqfrbyj | Vdjp | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Tlhmqdg | Vsv | $12.7 Bil | |
CTLT
| Catalent Inc | Ysrsdrbc | Hzxmmy | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Nqhcnrjx | Rlf | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Gqvnncnwx | Qyh | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Xqxrmqbdp | Qbjdrjt | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Qdqgmlnxk | Drhq | $3.1 Bil |